切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - Flk1 - DGAT - DREADD Ligands - Thymidylate Synthase - Calcium-Activated Potassium (KCa) Channels

11件产品中的 1-10

页面
每页
清除全部
  1. Midostaurin (PKC412)
    B3709 Midostaurin (PKC412)
    中文名: 米哚妥林
    Target: PKC|PKA|KDR|Flk1|PPK|c-Syk|CDK1/CyclinB
    Summary: PKC抑制剂
      ≥57.1 mg/mL
      insoluble in H2O
  2. Raltitrexed
    B1476 Raltitrexed
    中文名: 雷替曲塞
    Target: Thymidylate Synthase
    Summary: 胸苷酸合酶抑制剂
      ≥154 mg/mL
      insoluble in H2O
  3. Dequalinium Chloride
    B2191 Dequalinium Chloride
    中文名: 地喹氯铵
    Target: PKC|Calcium-Activated Potassium (KCa) Channels
    Summary: PKC抑制剂
      insoluble in DMSO
      insoluble in H2O
  4. Zonisamide
    A5354 Zonisamide
    中文名: 唑尼沙胺
    Target: Voltage-gated Sodium (NaV) Channels|Voltage-gated Calcium Channels (CaV)|Carbonic Anhydrases|Calcium-Activated Potassium (KCa) Channels
    Summary: 抗惊厥和机械效应的抗癫痫药
      ≥8.35 mg/mL
      insoluble in H2O
  5. Brivanib (BMS-540215)
    A2597 Brivanib (BMS-540215)
    中文名: 布立尼布
    Target: VEGFR|FGFR|Flk1
    Summary: VEGFR-2的ATP竞争性抑制剂
      ≥18.5 mg/mL
      insoluble in H2O
  6. TRAM-34
    A1888 TRAM-34
    Target: Calcium-Activated Potassium (KCa) Channels
    Summary: KCa3.1阻断剂
      ≥17.25 mg/mL
      insoluble in H2O
  7. Clozapine N-oxide(CNO)
    A3317 Clozapine N-oxide(CNO)
     1 Citation
    中文名: 氯氮平的N-氧化物
    Target: DREADD Ligands
    Summary: Clozapine代谢产物,用于化学遗传学
      ≥17.15 mg/mL
      ≥49 mg/mL
  8. AZD7687
    A3215 AZD7687
    Target: DGAT
    Summary: 强效的选择性DGAT抑制剂
      Soluble in DMSO
  9. Pemetrexed
    A4390 Pemetrexed
     1 Citation
    中文名: 培美曲塞二钠盐
    Target: Thymidylate Synthase|DHFR|GARFT
    Summary: TS、DHFR、GARFT和AICARFT抑制剂
      ≥15.68 mg/mL
      ≥30.67 mg/mL
  10. A922500
    A4382 A922500
    Target: DGAT
    Summary: DGAT-1抑制剂
      ≥21.25 mg/mL
      insoluble in H2O

11件产品中的 1-10

页面
每页